In the established low-antigen orthotopic mouse model, the hCT3 AbTCR T cell group regressed the tumor better than CT3 CAR T cell, with 3 out of 4 mice showing partial responses and a mean regression of 80.45% at day 28 post infusion (Figures 3J–3L). This evidence concerns the gene CAGE1 and neoplasm.